Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers.
Publication
, Journal Article
Duda, DG; Jain, RK; Willett, CG
Published in: J Clin Oncol
September 10, 2007
Although still in very early stages of clinical development, the combination of antiangiogenics with contemporary chemoradiotherapy regimens has emerged as a feasible and promising approach to many cancers. We review the rationale and the current understanding of antiangiogenics and their therapeutic potential in combination with chemoradiotherapy. Finally, we offer a perspective on future research directions aimed at making this complex therapeutic approach successful in the clinic.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
September 10, 2007
Volume
25
Issue
26
Start / End Page
4033 / 4042
Location
United States
Related Subject Headings
- Radiotherapy, Adjuvant
- Oncology & Carcinogenesis
- Neoplasms
- Humans
- Combined Modality Therapy
- Animals
- Angiogenesis Inhibitors
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Duda, D. G., Jain, R. K., & Willett, C. G. (2007). Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers. J Clin Oncol, 25(26), 4033–4042. https://doi.org/10.1200/JCO.2007.11.3985
Duda, Dan G., Rakesh K. Jain, and Christopher G. Willett. “Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers.” J Clin Oncol 25, no. 26 (September 10, 2007): 4033–42. https://doi.org/10.1200/JCO.2007.11.3985.
Duda DG, Jain RK, Willett CG. Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers. J Clin Oncol. 2007 Sep 10;25(26):4033–42.
Duda, Dan G., et al. “Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers.” J Clin Oncol, vol. 25, no. 26, Sept. 2007, pp. 4033–42. Pubmed, doi:10.1200/JCO.2007.11.3985.
Duda DG, Jain RK, Willett CG. Antiangiogenics: the potential role of integrating this novel treatment modality with chemoradiation for solid cancers. J Clin Oncol. 2007 Sep 10;25(26):4033–4042.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
September 10, 2007
Volume
25
Issue
26
Start / End Page
4033 / 4042
Location
United States
Related Subject Headings
- Radiotherapy, Adjuvant
- Oncology & Carcinogenesis
- Neoplasms
- Humans
- Combined Modality Therapy
- Animals
- Angiogenesis Inhibitors
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences